Stay updated on Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide banner announces an NIH terminology transition, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T12:51:04.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T14:19:48.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error page instead of showing the study record details. This indicates the page content is blocked or temporarily unavailable, with the usual header and footer still visible.
    Difference
    17%
    Check dated 2026-09-23T20:32:58.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.6 to v3.7.0 to reflect a newer version of the page content.
    Difference
    0.0%
    Check dated 2026-09-16T22:26:10.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6. This indicates a minor update to the page's revision metadata rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-09-02T19:30:47.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    A new line under Other Study ID Numbers adds 2017 (U.S. NIH Grant/Contract) as an identifier for the study. This links the trial to NIH funding and clarifies the funding source in the record.
    Difference
    0.0%
    Check dated 2026-08-26T19:42:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.